Efamol Overview

  • Year Founded
  • 1978

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Efamol General Information

Description

Developer of essential fatty acid-based products designed to help maintain and improve people's health. The company's products are based in botanical and marine oils, extracted from their natural sources, enabling consumers to improve the function of the nervous, immune, cardiovascular, gastrointestinal, respiratory and reproductive systems.

Contact Information

Website
www.efamol.com
Formerly Known As
Oval (1795) Limited
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Brackenholme Business Park
  • Brackenholme, North Yorkshire
  • Selby Y08 6EL
  • England, United Kingdom
+44 0800
Primary Industry
Personal Products
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Wassen International
Corporate Office
  • Brackenholme Business Park
  • Brackenholme, North Yorkshire
  • Selby Y08 6EL
  • England, United Kingdom
+44 0800

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Efamol Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Efamol‘s full profile, request access.

Request a free trial

Efamol Patents

Efamol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2006067379-A1 Use of essential fatty acid molecules Inactive 23-Dec-2004
GB-0428166-D0 Use of essentially fatty acid molecules Inactive 23-Dec-2004
JP-H05194244-A Drug containing essential fatty acid Inactive 24-Jul-1991
JP-H05178744-A Method for medical treatment using fatty acid Inactive 05-Jun-1991
JP-H05201924-A Fatty acid composition Active 03-Jun-1991 A61K31/23
To view Efamol’s complete patent history, request access »

Efamol Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Efamol‘s full profile, request access.

Request a free trial

Efamol FAQs

  • When was Efamol founded?

    Efamol was founded in 1978.

  • Where is Efamol headquartered?

    Efamol is headquartered in Selby, United Kingdom.

  • What industry is Efamol in?

    Efamol’s primary industry is Personal Products.

  • Is Efamol a private or public company?

    Efamol is a Private company.

  • What is Efamol’s current revenue?

    The current revenue for Efamol is .

  • Who are Efamol’s investors?

    Royal Numico and Scotia Pharmaceuticals have invested in Efamol.

  • When was Efamol acquired?

    Efamol was acquired on 01-Jan-2006.

  • Who acquired Efamol?

    Efamol was acquired by Wassen International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process